Northern Trust Corp Ani Pharmaceuticals Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Northern Trust Corp holds 187,525 shares of ANIP stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

187,525

Previous 167,745 11.79%

Holding current value

$10.6 Million

Previous $10.7 Million 4.73%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$54.33 - $65.72 $1.07 Million - $1.3 Million	19,780 Added 11.79%	187,525 $11.2 Million
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $257,473 - $302,739	4,399 Added 2.69%	167,745 $10.7 Million
Q1 2024 May 14, 2024	SELL	$54.2 - $69.69 $203,575 - $261,755	-3,756 Reduced 2.25%	163,346 $11.3 Million
Q4 2023 Feb 13, 2024	SELL	$48.72 - $65.43 $150,203 - $201,720	-3,083 Reduced 1.81%	167,102 $9.21 Million
Q3 2023 Nov 13, 2023	BUY	$50.28 - $64.61 $786,027 - $1.01 Million	15,633 Added 10.12%	170,185 $9.88 Million
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $548,535 - $791,839	14,710 Added 10.52%	154,552 $8.32 Million
Q1 2023 May 15, 2023	SELL	$37.61 - $45.72 $62,883 - $76,443	-1,672 Reduced 1.18%	139,842 $5.55 Million
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $151,046 - $198,633	4,735 Added 3.46%	141,514 $5.69 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $25,206 - $32,118	845 Added 0.62%	136,779 $4.4 Million
Q2 2022 Aug 12, 2022	BUY	$23.09 - $33.46 $261,678 - $379,202	11,333 Added 9.1%	135,934 $4.03 Million
Q1 2022 May 13, 2022	SELL	$26.91 - $47.15 $31,161 - $54,599	-1,158 Reduced 0.92%	124,601 $3.5 Million
Q4 2021 Feb 08, 2022	BUY	$32.97 - $56.85 $243,120 - $419,211	7,374 Added 6.23%	125,759 $5.8 Million
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $5,190 - $7,054	-196 Reduced 0.17%	118,385 $3.89 Million
Q2 2021 Aug 13, 2021	BUY	$31.86 - $38.6 $48,682 - $58,980	1,528 Added 1.31%	118,581 $4.16 Million
Q1 2021 May 12, 2021	SELL	$28.4 - $36.14 $216,947 - $276,073	-7,639 Reduced 6.13%	117,053 $4.23 Million
Q4 2020 Feb 11, 2021	BUY	$23.69 - $31.47 $22,742 - $30,211	960 Added 0.78%	124,692 $3.62 Million
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $115,306 - $144,680	-4,371 Reduced 3.41%	123,732 $3.49 Million
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $98,589 - $165,029	-3,294 Reduced 2.51%	128,103 $4.14 Million
Q1 2020 May 14, 2020	BUY	$30.35 - $67.14 $84,676 - $187,320	2,790 Added 2.17%	131,397 $5.35 Million
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $250,981 - $360,033	-4,510 Reduced 3.39%	128,607 $7.93 Million
Q3 2019 Nov 13, 2019	BUY	$64.7 - $85.39 $910,717 - $1.2 Million	14,076 Added 11.82%	133,117 $9.7 Million
Q2 2019 Aug 13, 2019	BUY	$67.77 - $82.2 $162,919 - $197,608	2,404 Added 2.06%	119,041 $9.79 Million
Q1 2019 May 13, 2019	SELL	$45.83 - $70.54 $24,106 - $37,104	-526 Reduced 0.45%	116,637 $8.23 Million
Q4 2018 Feb 12, 2019	SELL	$41.17 - $56.44 $38,205 - $52,376	-928 Reduced 0.79%	117,163 $5.27 Million
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $68,040 - $91,671	1,285 Added 1.1%	118,091 $6.68 Million
Q2 2018 Sep 18, 2018	SELL	$56.38 - $68.08 $40,029 - $48,336	-710 Reduced 0.6%	116,806 $7.8 Million
Q2 2018 Aug 14, 2018	BUY	$56.38 - $68.08 $305,579 - $368,993	5,420 Added 4.84%	117,516 $7.85 Million
Q1 2018 May 09, 2018	SELL	$56.98 - $72.41 $85,754 - $108,977	-1,505 Reduced 1.32%	112,096 $6.53 Million
Q4 2017 Feb 14, 2018	SELL	$53.3 - $74.56 $2,291 - $3,206	-43 Reduced 0.04%	113,601 $7.32 Million
Q3 2017 Nov 13, 2017	BUY	$43.46 - $52.49 $4.94 Million - $5.97 Million	113,644	113,644 $5.97 Million

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Ani Pharmaceuticals Inc Transaction History